Search Results - mapk

1 Results Sort By:
Methods of Producing T-cell Populations Using P38 MAPK Inhibitors
Abstract: Adoptive cell therapy (ACT) uses cancer reactive T-cells to effectively treat patients. However, several obstacles inhibit the successful use of ACT for cancer treatment.  Current approaches for the expansion of T-cells may produce T-cells with a terminally differentiated phenotype that is associated with diminished anti-tumor activity and...
Published: 4/8/2024   |   Inventor(s): Nicholas Restifo, Shashankkumar Patel
Keywords(s): Immunotherapy. Restifo, inhibitor, Mapk, P38, T-CELLS
Category(s): Application > Therapeutics, Collaboration Sought > Licensing, TherapeuticArea > Oncology